Advertisement

Citation tools

Horwitz, Steven M. et al "Activity of the PI3K-δ,γ inhibitor duvelisib in a phase I trial and preclinical models of T-cell lymphoma." Blood (2017): blood-2017-08-802470. Web. 17 Jan. 2018.